<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251120068054N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-12-02</date_registration>
      <primary_sponsor>The University of kharazmi</primary_sponsor>
      <public_title>Comparison of the effect of a course of comprehensive corrective exercises with and without muscle energy technique on shoulder strength and proprioception, balance, respiratory function and posture of girls with upper cross syndrome with respiratory pattern disorder.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of a course of comprehensive corrective exercises with and without muscle energy technique on shoulder strength and proprioception, balance, respiratory function and posture of girls with upper cross syndrome with respiratory pattern disorder.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-12-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>36</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87751</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Factorial, Purpose: Supportive, Randomization description: This study has been randomized through simple randomization statistical method using block design. This study will be allocated to 2 intervention groups and 1 control group with the help of a web-based program (randomizer.org). A member of the research team who will not be involved in this part will be asked to perform the random allocation sequence of the samples using a computer program. Sealed envelopes with the random sequence will be used to conceal the allocation, Blinding description: In this study, the person responsible for analyzing the data is unaware of the individuals and groupings and only analyzes the results and statistical data in the two tests taken.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Upper Crossed Syndrome with Respiratory Pattern Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: This group will perform comprehensive corrective exercises for 8 weeks, 3 sessions per week, each session lasting 50 minutes, focusing on the muscles that are restricted and tight in upper crossed syndrome. The exercises consist of 3 phases: 1- Initial phase 2- Improvement phase 3- Maintenance phase. Foam rolls, Therabands, exercise balls, dumbbells, and balance boards will be used in these exercises. Intervention 2: Intervention group: This group will perform comprehensive corrective exercises along with muscle energy techniques for 8 weeks, 3 sessions per week, each session lasting 60 minutes. Intervention 3: Control group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Aylin mansury</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam Hossein Square, Jahan Ara Street, Mehregan Building 2, Unit 1, No. 136</address>
        <city>Varamin</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3371943557</zip>
        <telephone>009836265011</telephone>
        <email>aylinmansury21@gmail.com</email>
        <affiliation>The University of Kharazmi</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Syed Sadroddin Shojaeddin</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Mirdamad Blvd., South Razan St., Shahid Keshvari Educational and Sports Complex</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1544733111</zip>
        <telephone>+98 21 3451 2001</telephone>
        <email>Shojaeddin@khu.ac.ir</email>
        <affiliation>The University of Kharazmi</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Girls aged 18 to 25 years
Having 3 simultaneous symptoms of kyphosis (angle of 42 degrees and more), forward head (angle of 44 degrees and more), and rounded shoulders (49 degrees and more)
Having a respiratory pattern disorder
Confirmation from a specialist physician</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>25 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>The individual's unwillingness or unwillingness to participate in or continue to participate in the research.
Any injury or abnormality affecting the research process, with the exception of respiratory pattern disorder and upper cross syndrome.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R29.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Abnormal posture</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: This group will perform comprehensive corrective exercises for 8 weeks, 3 sessions per week, each session lasting 50 minutes, focusing on the muscles that are restricted and tight in upper crossed syndrome. The exercises consist of 3 phases: 1- Initial phase 2- Improvement phase 3- Maintenance phase. Foam rolls, Therabands, exercise balls, dumbbells, and balance boards will be used in these exercises.</i_keyword>
      <i_keyword>Intervention group: This group will perform comprehensive corrective exercises along with muscle energy techniques for 8 weeks, 3 sessions per week, each session lasting 60 minutes.</i_keyword>
      <i_keyword>Control group:</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Shoulder internal and external rotator strength. Timepoint: Pre-test and post-test. Method of measurement: Isokinetic device.</prim_outcome>
      <prim_outcome>Proprioception of the internal and external rotator muscles of the shoulder. Timepoint: Pre-test and post-test. Method of measurement: Isokinetic device.</prim_outcome>
      <prim_outcome>Static and dynamic balance. Timepoint: Pre-test and post-test. Method of measurement: Biodex balance device.</prim_outcome>
      <prim_outcome>Posture. Timepoint: Pre-test and post-test. Method of measurement: Flexible ruler, digital camera, and Kinovea software.</prim_outcome>
      <prim_outcome>Respiratory function. Timepoint: Pre-test and post-test. Method of measurement: spirometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The University of kharazmi</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-10-21</approval_date>
        <contact_name>Kharazmi University</contact_name>
        <contact_address>Simaye iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
